Assessment of Spontaneous Retinal Arterial Pulsations in Acute Central Retinal Vein Occlusions

Table 2

Patients’ characteristics, diagnostic features, and follow-up parameters compared between “pulse +” and “pulse −” groups.

	Pulse +	Pulse −	value
Mean age in year ± SD	54.30 ± 16.60	73.45 ± 10.76	0.001
Male-to-female ratio	14 : 9	6 : 5	0.505
Systemic hypertension	21.74%	45.45%	0.232
Ocular hypertension/glaucoma	17.39%	0%	0.280
Diabetes mellitus	8.69%	0%	0.451
PAMM	52.17%	27.27%	0.271
Papillary edema at baseline	56.52%	63.63%	0.693
Papillary edema at month 6	0%	9.09%	0.483
Macular edema at baseline	60.87%	90.91%	0.113
Macular edema at month 6	13.04%	27.27%	0.363
Mean CMT at baseline (μm) ± SD	530.83 ± 294.16	822.55 ± 304.62	0.012
Mean CMT at month 6 (μm) ± SD	282.65 ± 127.29	305.73 ± 192.89	0.679
SRD at baseline	43.48%	81.82%	0.064
SRD at month 6	13.04%	18.18%	0.692
Mean number of anti-VEFG injections	3.5	2.8	0.349
Mean number of dexamethasone implants	1.33	1.50	0.725
Mean BCVA at baseline (logMAR)	0.80	1.10	0.211
Mean BCVA at month 6 (logMAR)	0.40	0.76	0.075

SD: standard deviation, PAMM: paracentral acute middle maculopathy, CMT: central macular thickness, SRD: serous retinal detachment, VEGF: vascular endothelial growth factor, and BCVA: best-corrected visual acuity; value <0.05.